الاثنين، 7 مارس 2016

ScienceDaily: Top News

ScienceDaily: Top News

Omalizumab decreases colds in inner-city children with asthma

Posted: 06 Mar 2016 05:38 AM PST

Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers report. Omalizumab, sold under the brand name Xolair, is an injectable antibody that can be used to treat asthma cases not controlled by inhaled corticosteroids.

Asthma symptoms linked to increased stress, anxiety levels in teens

Posted: 06 Mar 2016 05:38 AM PST

Common asthma symptoms like waking up in the middle of the night and shortness of breath are associated with increased levels of stress and anxiety in teens with asthma. In a small study of 38 asthma patients ages 14-17, researchers found that their average scores for stress and anxiety levels were higher than those seen in the general population.
مرسلة بواسطة في

ليست هناك تعليقات:

إرسال تعليق

الاشتراك في: تعليقات الرسالة (Atom)